Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Teva announced the launch of Linezolid Injection, the generic version of Pfizer’s Zyvox Injection.
Zyvox injection is an oxazolidinedione antibiotic indicated for the treatment of infections caused by susceptible Gram (+) bacteria: nosocomial pneumonia, community-acquired pneumonia; complicated skin and skin structure infections, including diabetic foot infections, without concomitant osteomyelitis; uncomplicated skin and skin structure infections; and vancomycin-resistant Enterococcus faecium infections.
RELATED: Antibiotic Formulations
Linezolid Injection is available as a 600mg/300mL strength as 10-count single-use flexible plastic infusion bags.
For more information call (888) 838-2872 or visit TevaGenerics.com.
Related Content
